Literature DB >> 2364772

[Gallstone ileus. A report of 104 cases].

J Hildebrandt1, U Herrmann, H Diettrich.   

Abstract

An analysis of 104 cases of gallstone ileus in 102 patients is presented. Biliary stones reach the intestinal tract through a biliodigestive fistula in 80-85% and on natural way in 15-20%. Clinical symptoms depend on mechanism of obstruction. It shows 3 forms of course: peritonitical form (20%), remittent form (30%) and typical intestinal obturation (50%). Roentgenological findings show aerobilia in 36%, dystope radiopaque stones in 8% and signs of obstruction in 97% of investigations. The main concern in gallstone ileus should be to relieve the intestinal obstruction and not cholelithiasis. The mortality rate declined during reported time from 40-50% to 25%.

Entities:  

Mesh:

Year:  1990        PMID: 2364772

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  5 in total

1.  Gallstone ileus--beware the silent second stone.

Authors:  J B Davies; P C Sedman; E A Benson
Journal:  Postgrad Med J       Date:  1996-05       Impact factor: 2.401

Review 2.  Laparoscopic Management of a Proximal Jejunal Gallstone Ileus with Patulous Ampulla and Choledochal Cyst-a Report of Unusual Presentation and a Review.

Authors:  Rajvilas Anil Narkhede; Vijaykumar C Bada; Lakshmi Kumari Kona
Journal:  Indian J Surg       Date:  2016-12-28       Impact factor: 0.656

3.  Resolution of gallstone ileus with spontaneous evacuation of gallstone: a case report.

Authors:  Anupama Tandon; Thingujam Usha; Satish K Bhargava; Shuchi Bhatt; Sumeet Bhargava; Meenakshi Prakash; Aggrwal Anupkumar Durgadas
Journal:  Indian J Surg       Date:  2013-02-02       Impact factor: 0.656

Review 4.  Gallstone ileus--clinical and therapeutic aspects.

Authors:  M Beuran; I Ivanov; M D Venter
Journal:  J Med Life       Date:  2010 Oct-Dec

5.  Laparoscopic management of gallstone ileus.

Authors:  D J Soto; S J Evan; M S Kavic
Journal:  JSLS       Date:  2001 Jul-Sep       Impact factor: 2.172

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.